|
The investigation determined that higher than expected vitros carbamazepine (crbm) results were obtained from two levels of vitros therapeutic drug monitoring (tdm) performance verifier (pv) quality control (qc) material using vitros chemistry products crbm slides lot 3916-0125-4879 on a vitros xt 7600 integrated system.The assignable cause of the events observed prior to 27 january 2025 is an instrument related issue.The assignable cause of the events observed on 28 january 2025 is user error due to the customer not recalibrating vitros crbm slide lot 3916-0125-4879 after critical service actions had been performed on the immunometric subsystem.A review of historical quality control results for vitros crbm slide lot 3916-0125-4879 indicate that the vitros tdm pvi and tdm pviii qc results were imprecise during the timeframe of the initial events, only on j76001919.Historical qc results for the same timeframe on alternate j76001957 were determined to be acceptable using the same vitros crbm slide lot 3916-0125-4879, indicating that a vitros crbm slide lot 3916-0125-4879 issue is not a contributor to the event.An ortho field engineer (fe) went onsite on 27 january 2025 to optimize the affected instrument.The ortho fe's interventions included adjustments to the immunometric subsystem of the instrument, which is the subsystem responsible for vitros crbm slide processing.After a recalibration event post-service, vitros crbm qc results were determined to be accurate and precise.
|